🚀 VC round data is live in beta, check it out!
- Public Comps
- Perpetua Medical
Perpetua Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Perpetua Medical and similar public comparables like BBS-Bioactive Bone, Inhalation Sciences SWE, Work Medical Technology Group, Luxbright and more.
Perpetua Medical Overview
About Perpetua Medical
Perpetua Medical AB is engaged in healthcare sector. The company develops systems and solutions that plan to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog and Pharmacolog Dashboard.
Founded
2007
HQ

Employees
11
Website
Sectors
Financials (FY)
EV
$1M
Perpetua Medical Financials
Perpetua Medical reported last fiscal year revenue of $2M and EBITDA of $480K.
In the same fiscal year, Perpetua Medical generated $830K in gross profit, $480K in EBITDA, and $268K in net income.
Perpetua Medical P&L
In the most recent fiscal year, Perpetua Medical reported revenue of $2M and EBITDA of $480K.
Perpetua Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $830K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 52% | XXX | XXX | XXX |
| EBITDA | — | XXX | $480K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 30% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 14% | XXX | XXX | XXX |
| Net Profit | — | XXX | $268K | XXX | XXX | XXX |
| Net Margin | — | XXX | 17% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Perpetua Medical Stock Performance
Perpetua Medical has current market cap of $2M, and enterprise value of $1M.
Market Cap Evolution
Perpetua Medical's stock price is $0.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $2M | 0.3% | XXX | XXX | XXX | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPerpetua Medical Valuation Multiples
Perpetua Medical trades at 0.8x EV/Revenue multiple, and 2.5x EV/EBITDA.
Perpetua Medical Financial Valuation Multiples
As of April 20, 2026, Perpetua Medical has market cap of $2M and EV of $1M.
Equity research analysts estimate Perpetua Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Perpetua Medical has a P/E ratio of 6.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 5.4x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.4x | XXX | XXX | XXX |
| P/E | — | XXX | 6.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (1.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Perpetua Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Perpetua Medical Margins & Growth Rates
Perpetua Medical's revenue in the last fiscal year grew by 110%.
Perpetua Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Perpetua Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 110% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 30% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (344%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Perpetua Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Perpetua Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| BBS-Bioactive Bone | XXX | XXX | XXX | XXX | XXX | XXX |
| Inhalation Sciences SWE | XXX | XXX | XXX | XXX | XXX | XXX |
| Work Medical Technology Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Luxbright | XXX | XXX | XXX | XXX | XXX | XXX |
| Adiuvo Investments | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Perpetua Medical M&A Activity
Perpetua Medical acquired XXX companies to date.
Last acquisition by Perpetua Medical was on XXXXXXXX, XXXXX. Perpetua Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Perpetua Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPerpetua Medical Investment Activity
Perpetua Medical invested in XXX companies to date.
Perpetua Medical made its latest investment on XXXXXXXX, XXXXX. Perpetua Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Perpetua Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Perpetua Medical
| When was Perpetua Medical founded? | Perpetua Medical was founded in 2007. |
| Where is Perpetua Medical headquartered? | Perpetua Medical is headquartered in Sweden. |
| How many employees does Perpetua Medical have? | As of today, Perpetua Medical has over 11 employees. |
| Is Perpetua Medical publicly listed? | Yes, Perpetua Medical is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Perpetua Medical? | Perpetua Medical trades under PERP B ticker. |
| When did Perpetua Medical go public? | Perpetua Medical went public in 2015. |
| Who are competitors of Perpetua Medical? | Perpetua Medical main competitors are BBS-Bioactive Bone, Inhalation Sciences SWE, Work Medical Technology Group, Luxbright. |
| What is the current market cap of Perpetua Medical? | Perpetua Medical's current market cap is $2M. |
| What is the current revenue of Perpetua Medical? | Perpetua Medical's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of Perpetua Medical? | Current revenue multiple of Perpetua Medical is 0.8x. |
| Is Perpetua Medical profitable? | No, Perpetua Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.